Abstract:Purpose: WNT/β-catenin gene SOX17 was reported frequently methylated in colonic and hepatic cancer. To explore epigenetic changes of SOX17 as esophageal cancer marker and therapeutic target, epigenetic regulation and tumor suppressor function of SOX17 were analyzed in study. Experimental Design: Methylation specific PCR (MSP) was employed to examine SOX17 methylation in 8 esophageal cancer cell lines and 9 normal mucosa, 60 dysplasia and 169 cancer tissue. Semi-quantitative RT-PCR method was used to examine SOX17 expression before and after 5-aza-2′-deoxycytidine treatment of esophageal cancer cells. Expression of SOX17 and β-catenin were detected by immunohistochemistry (IHC) in esophageal cancer and adjacent tissue. Luciferase reporter assay, colony formation, transfection and western blotting were applied to analyze SOX17 function in WNT signal pathway. Prediction software and miRNAs related detection methods were preformed to evaluate miRNA regulation of SOX17. Results: SOX17 was silenced by promoter region methylation and reactivated by 5-aza-2′-deoxycytidine treatment in esophageal cancer cell lines. Loss of SOX17 expression and accumulation of β-catenin in nuclear and cytoplasm were associated with promoter region hypermethylation in esophageal cancer(test, P=0.0359, P=0.0105). Restoration of SOX17 expression inhibited β-catenin/TCF-dependent transcription and colony formation. The presence of SOX17 methylation correlated significantly with alcohol history in esophageal cancer(test, P=0.0057). MiR-141 was also found to down-regulate SOX17 expression and activated the WNT signal pathway. Conclusions: SOX17 is frequently methylated in esophageal cancer, and SOX17 expression is regulated both by miR-141 and promoter region methylation. Loss of SOX17 removes the normal inhibition of WNT signaling and promotes esophageal tumorigenesis. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 3993. doi:1538-7445.AM2012-3993

Induction and Down-Regulation of Sox17 and Its Possible Roles During the Course of Gastrointestinal Tumorigenesis.

Sox17 Regulates Proliferation and Cell Cycle During Gastric Cancer Progression

Decreased Expression Of Sox7 Correlates With The Upregulation Of The Wnt/Beta-Catenin Signaling Pathway And The Poor Survival Of Gastric Cancer Patients

Silencing Sox2 Induced Mesenchymal-Epithelial Transition And Its Expression Predicts Liver And Lymph Node Metastasis Of Crc Patients

Epigenetic Inactivation of the Canonical Wnt Antagonist Sry-Box Containing Gene 17 in Colorectal Cancer

Protocadherin 17 Acts As a Tumour Suppressor Inducing Tumour Cell Apoptosis and Autophagy, and is Frequently Methylated in Gastric and Colorectal Cancers

SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer

Abstract LB-90: Sox17 Antagonizes Wnt/ß-catenin Signaling Pathway in HCC

Homeobox D10 Gene, a Candidate Tumor Suppressor, is Downregulated Through Promoter Hypermethylation and Associated with Gastric Carcinogenesis

Inhibition of Sox17 by Microrna 141 and Methylation Activates the Wnt Signaling Pathway in Esophageal Cancer

SOX17 enables immune evasion of early colorectal adenomas and cancers

HoxC6 Functions As an Oncogene and Isoform HoxC6-2 May Play the Primary Role in Gastric Carcinogenesis

SOX10, a Novel HMG-box-containing Tumor Suppressor, Inhibits Growth and Metastasis of Digestive Cancers by Suppressing the Wnt/β-catenin Pathway.

Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells

Intervention of epithelial mesenchymal transition against colon cancer cell growth and metastasis based on SOX21/POU4F2/Hedgehog signaling axis

Preliminary Screening of Downstream Proteins of Sox2 and Role of Sox2 in Colonic Cancer Cell Migration and Invasion

SOX15 Exerts Antitumor Function in Glioma by Inhibiting Cell Proliferation and Invasion Via Downregulation of Wnt/β-catenin Signaling.

SOX17 Antagonizes WNT/β-catenin Signaling Pathway in Hepatocellular Carcinoma

Sox17, the Canonical Wnt Antagonist, is Epigenetically Inactivated by Promoter Methylation in Human Breast Cancer

Effects of SOX15 on the colorectal cancer cells via downregulation of the Wnt/β-catenin signaling pathway.

Abstract 3993: MiRNA-141 and methylation regulation of WNT signal pathway by suppressing SOX17 i n esophageal cancer